Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2659 |
|
Actual shortage: | 251 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2399 (90%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
27 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-ESCITALOPRAM | 20MG | TABLET | Resolved | 2020-02-21 | 2020-03-19 | 106928 |
TEVA-ESCITALOPRAM | 20MG | TABLET | Resolved | 2020-02-21 | 2020-03-12 | 106948 |
TEVA-ESCITALOPRAM | 20MG | TABLET | Resolved | 2020-03-26 | 2020-06-18 | 109598 |
TEVA-ESCITALOPRAM | 10MG | TABLET | Resolved | 2020-04-02 | 2020-05-08 | 110688 |
TEVA-ESCITALOPRAM | 20MG | TABLET | Resolved | 2020-04-16 | 2020-06-18 | 112379 |
TEVA-ESCITALOPRAM | 10MG | TABLET | Resolved | 2020-07-09 | 2021-02-05 | 119877 |
TEVA-ESCITALOPRAM | 20MG | TABLET | Resolved | 2020-08-20 | 2020-09-24 | 122717 |
TEVA-ESCITALOPRAM | 20MG | TABLET | Resolved | 2021-02-18 | 2021-03-18 | 134349 |
TEVA-ESCITALOPRAM | 20MG | TABLET | Resolved | 2022-09-30 | 2022-12-08 | 170779 |
TEVA-ESCITALOPRAM | 10MG | TABLET | Resolved | 2022-09-30 | 2022-12-02 | 170798 |
TEVA-ESCITALOPRAM | 20MG | TABLET | Resolved | 2022-12-22 | 2023-04-28 | 179183 |
TEVA-ESCITALOPRAM | 20MG | TABLET | Resolved | 2023-01-12 | 2023-04-28 | 180906 |
TEVA-ESCITALOPRAM | 10MG | TABLET | Resolved | 2023-06-08 | 2023-06-27 | 194141 |
TEVA-ESCITALOPRAM | 10MG | TABLET | Resolved | 2023-06-16 | 2023-06-27 | 195133 |
TEVA-ERLOTINIB | 100MG | TABLET | Resolved | 2020-01-30 | 2020-03-12 | 104896 |
TEVA-ERLOTINIB | 150MG | TABLET | Resolved | 2022-12-01 | 2023-04-28 | 176830 |
TEVA-ENTACAPONE | 200MG | TABLET | Resolved | 2019-12-12 | 2020-03-05 | 101154 |
TEVA-ENTACAPONE | 200MG | TABLET | Resolved | 2020-04-10 | 2020-04-23 | 111832 |
TEVA-ENTACAPONE | 200MG | TABLET | Resolved | 2022-01-20 | 2022-02-25 | 153159 |
TEVA-ENTACAPONE | 200MG | TABLET | Resolved | 2023-07-19 | 2023-08-04 | 199190 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-PIOGLITAZONE | 15MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65026 |
TEVA-PIOGLITAZONE | 30MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65030 |
TEVA-PIOGLITAZONE | 45MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65033 |
TEVA-PAROXETINE | 10MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81313 |
TEVA-PAROXETINE | 30MG | TABLET | Discontinued | 2019-12-09 | 2019-12-09 | 100540 |
TEVA-PAROXETINE | 20MG | TABLET | Discontinued | 2019-12-09 | 2019-12-09 | 100547 |
TEVA-PAROXETINE | 10MG | TABLET | Discontinued | 2020-02-21 | 2020-02-21 | 106898 |
TEVA-PAROXETINE | 30MG | TABLET | Discontinued | 2020-02-21 | 2020-02-21 | 106901 |
TEVA-PANTOPRAZOLE MAGNESIUM | 40MG | TABLET (DELAYED-RELEASE) | Discontinued | 2021-02-12 | 2021-02-12 | 133891 |
TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Discontinued | 2018-10-12 | 2018-10-12 | 63946 |
TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Discontinued | 2018-10-12 | 2018-10-12 | 63949 |
TEVA-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2020-07-10 | 2020-07-10 | 120056 |
TEVA-NORFLOXACIN | 400MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65013 |
TEVA-NAPROXEN SODIUM DS | 550MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81350 |
TEVA-NAPROXEN | 250MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14055 |
TEVA-MIRTAZAPINE | 30MG | TABLET | Discontinued | 2021-02-12 | 2021-02-12 | 133908 |
TEVA-METOPROLOL | 50MG | TABLET | Discontinued | 2020-07-10 | 2020-07-10 | 119976 |
TEVA-LOSARTAN/HCTZ | 100MG 12.5MG | TABLET | Discontinued | 2021-02-12 | 2021-02-12 | 133896 |
TEVA-LOSARTAN/HCTZ | 100MG 25MG | TABLET | Discontinued | 2021-02-12 | 2021-02-12 | 133899 |
TEVA-LOSARTAN/HCTZ | 50.0MG 12.5MG | TABLET | Discontinued | 2021-02-12 | 2021-02-12 | 133902 |